Not sure on this one, Pfizer CEO says the company is prepared to distribute "hundreds of thousands of doses,
- the firm is likely to have the key data from its late-stage trial by the end of October
- if FDA approval is secured the company is prepared
Weekend comments from the head of the company.
100s of 1,000s doesn't really cut it. It a start I guess.
More:
- On Saturday, Pfizer submitted a proposal to the FDA to expand the late-stage trial to include up to 44,000 participants (from its previous target of 30,000)
